Altra Evening Primrose Oil
Natural health product licensed in Canada
- Licence holder
- Altra Health Inc.
- NPN or DIN-HM
- 80076070
- Status
- Active licence
- Licence date
- 13 March 2017
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Oenothera biennis Source : Graine(s) | 1,000 milligramme | Not calculated |
Non-medicinal ingredients
Vitamine E, Eau purifiée, Gélatine, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 days |
Uses authorised in Canada
Source of essential fatty acids for the maintenance of good health. Source of omega-6 fatty acids for the maintenance of good health. Source of linoleic acid for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking blood thinners, anti-psychotics or if symptoms persist.
- Contre-indications
Do not use if you are taking black cohosh and/or chasteberry or are taking phenothiazines. Do not use if you have any seizure disorder, mania and/or schizophrenia. Do not take if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80076070
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.